CD274 and neoplasm: To demonstrate the response of PDOTSs to immune checkpoint blockades, PDOTSs from a tumor from a high‐level microsatellite instability (MSI‐H)‐harboring patient (CRC13) were treated with anti‐PD‐1 or anti‐PD‐L1 antibodies for 7 days.